Aspira Pathlab & Diagnostics Ltd. - Research Center
540788 ASPIRA Group (X) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
5.93 |
6.68 |
10.17 |
9.37 |
6.90 |
Operating profit |
-0.70 |
0.64 |
3.36 |
3.00 |
1.76 |
Interest |
0.19 |
0.22 |
0.23 |
0.14 |
0.48 |
Gross profit |
-0.65 |
0.55 |
3.19 |
2.91 |
1.42 |
EPS (Rs) |
-1.39 |
-0.26 |
2.25 |
2.09 |
0.75 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.24 |
0.13 |
0.06 |
0.05 |
0.14 |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
1.18 |
1.23 |
1.75 |
1.39 |
1.31 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
2.94 |
2.67 |
2.66 |
2.36 |
1.81 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
2.50 |
2.14 |
2.40 |
2.62 |
2.01 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.78 |
0.82 |
0.88 |
0.76 |
0.72 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
-1.43 |
-0.27 |
2.31 |
2.15 |
0.70 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
10.29 |
10.29 |
10.29 |
10.29 |
9.29 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-11.74 |
9.52 |
33.08 |
32.02 |
25.59 |
GPM (%) |
-10.46 |
8.07 |
31.17 |
30.87 |
20.15 |
NPM (%) |
-23.12 |
-3.97 |
22.61 |
22.80 |
9.94 |